Clinical Trials · NCT07121153
A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants When Injected Under the Skin.
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 36
- Start date
- Aug 2025
- Locations
- 1 site, China
- Primary endpoint
- Number of treatment emergent adverse events (TEAEs)